BTG (BTG LN)

Analysis

Health Care • United Kingdom

BTG plc was an international specialist healthcare company that developed and commercialized products targeting critical care, cancer, and other disorders. Its portfolio included interventional medicine products for liver tumors, emphysema, blood clots, and varicose veins, alongside specialty pharmaceuticals. The company was headquartered in London, United Kingdom, and was founded in 1948 as the National Research Development Corporation, later becoming BTG in 1998.

Refresh

Exchange Announcement • 02 Oct 2026 23:14

Total Voting Rights

Exchange Announcement • 23 Sep 2026 13:00

Acquisition

Exchange Announcement • 16 Sep 2026 17:49

Result of AGM

Exchange Announcement • 16 Sep 2026 13:00

AGM Statement

Exchange Announcement • 21 Aug 2026 16:04

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Total Voting Rights

Acquisition

Result of AGM

AGM Statement

Latest Red Flag Alert for Q2 2026 - Replacement